Advertisement
FANG vs PRME
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FANG is a Hold and PRME is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
FANG’s FA Score shows that 0 FA rating(s) are green whilePRME’s FA Score has 0 green FA rating(s).
- FANG’s FA Score: 0 green, 5 red.
- PRME’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
FANG’s TA Score shows that 3 TA indicator(s) are bullish while PRME’s TA Score has 4 bullish TA indicator(s).
- FANG’s TA Score: 3 bullish, 7 bearish.
- PRME’s TA Score: 4 bullish, 3 bearish.
Price Growth
FANG (@Oil & Gas Production) experienced а -4.09% price change this week, while PRME (@Biotechnology) price change was +4.63% for the same time period.
The average weekly price growth across all stocks in the @Oil & Gas Production industry was -1.24%. For the same industry, the average monthly price growth was +3.26%, and the average quarterly price growth was -0.52%.
The average weekly price growth across all stocks in the @Biotechnology industry was +2.69%. For the same industry, the average monthly price growth was +18.51%, and the average quarterly price growth was +31.06%.
Reported Earning Dates
FANG is expected to report earnings on Nov 10, 2025.
PRME is expected to report earnings on Aug 06, 2025.
Industries' Descriptions
@Oil & Gas Production (-1.24% weekly)The oil and gas production segment includes companies that specialize in exploration, development, and production of oil and natural gas. These companies are focused on upstream operations. Companies typically identify deposits, drill wells, and extract raw materials from underground. The industry also includes related services like rig operations, feasibility studies, machinery rentals etc. Several operators in this industry work with various types of contractors such as engineering procurement and construction contractors, as well as with joint-venture partners and oil field service companies. Oil and gas often involves large fixed costs of production; so, declining crude oil prices, for example, is a potential negative for this industry. Conoco Phillips, EOG Resources, Inc. and Pioneer Natural Resources Company are some examples of companies operating in this space.
@Biotechnology (+2.69% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
| FANG | PRME | FANG / PRME | |
| Capitalization | 35.6B | 577M | 6,170% |
| EBITDA | 6.17B | -200M | -3,084% |
| Gain YTD | -14.656 | 46.918 | -31% |
| P/E Ratio | 11.50 | N/A | - |
| Revenue | 8.34B | 3.85M | 216,823% |
| Total Cash | 582M | 144M | 404% |
| Total Debt | 6.8B | 121M | 5,621% |
FANG | PRME | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 59 | 32 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 50 Fair valued | 50 Fair valued | |
PROFIT vs RISK RATING 1..100 | 36 | 100 | |
SMR RATING 1..100 | 100 | 100 | |
PRICE GROWTH RATING 1..100 | 63 | 34 | |
P/E GROWTH RATING 1..100 | 100 | 100 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
FANG's Valuation (50) in the Oil And Gas Production industry is in the same range as PRME (50) in the null industry. This means that FANG’s stock grew similarly to PRME’s over the last 12 months.
FANG's Profit vs Risk Rating (36) in the Oil And Gas Production industry is somewhat better than the same rating for PRME (100) in the null industry. This means that FANG’s stock grew somewhat faster than PRME’s over the last 12 months.
FANG's SMR Rating (100) in the Oil And Gas Production industry is in the same range as PRME (100) in the null industry. This means that FANG’s stock grew similarly to PRME’s over the last 12 months.
PRME's Price Growth Rating (34) in the null industry is in the same range as FANG (63) in the Oil And Gas Production industry. This means that PRME’s stock grew similarly to FANG’s over the last 12 months.
PRME's P/E Growth Rating (100) in the null industry is in the same range as FANG (100) in the Oil And Gas Production industry. This means that PRME’s stock grew similarly to FANG’s over the last 12 months.
| FANG | PRME | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 81% | 1 day ago 71% |
| Stochastic ODDS (%) | 1 day ago 69% | 1 day ago 89% |
| Momentum ODDS (%) | 1 day ago 74% | N/A |
| MACD ODDS (%) | 1 day ago 64% | N/A |
| TrendWeek ODDS (%) | 1 day ago 67% | 1 day ago 82% |
| TrendMonth ODDS (%) | 1 day ago 68% | 1 day ago 75% |
| Advances ODDS (%) | 5 days ago 72% | 6 days ago 78% |
| Declines ODDS (%) | 1 day ago 64% | N/A |
| BollingerBands ODDS (%) | 1 day ago 75% | 1 day ago 90% |
| Aroon ODDS (%) | 1 day ago 68% | 1 day ago 82% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| MANA | 2.63 | 0.04 | +1.58% |
| Grayscale Decentraland Trust (MANA) | |||
| IBDT | 25.25 | -0.03 | -0.10% |
| iShares iBonds Dec 2028 Term Corp ETF | |||
| IBII | 25.60 | -0.08 | -0.30% |
| iShares iBonds Oct 2032 Term Tips ETF | |||
| HPI | 15.95 | -0.06 | -0.37% |
| John Hancock Preferred Income Fund | |||
| IEUS | 66.64 | -0.80 | -1.19% |
| iShares MSCI Europe Small-Cap ETF | |||
PRME and
Correlation & Price change
A.I.dvisor indicates that over the last year, PRME has been loosely correlated with CRSP. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if PRME jumps, then CRSP could also see price increases.
| Ticker / NAME | Correlation To PRME | 1D Price Change % | ||
|---|---|---|---|---|
| PRME | 100% | -10.72% | ||
| CRSP - PRME | 63% Loosely correlated | -6.54% | ||
| BEAM - PRME | 57% Loosely correlated | -7.51% | ||
| RXRX - PRME | 56% Loosely correlated | -1.14% | ||
| CRBU - PRME | 53% Loosely correlated | -5.29% | ||
| CCCC - PRME | 51% Loosely correlated | -11.34% | ||
More | ||||